Breaking News

You are here » Indian-Commodity  :  Corporate  :  Lupin Neurosciences receives positive CHMP opinion for NaMuscla

20-Oct2018

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), has adopted a positive opinion recommending the marketing authorization of NaMusclaim (mexiletine hydrochloride) for the symptomatic treatment of myotonia in adults with non-dystrophic myotonic (NDM) disorders.

The CHMP's positive opinion will now be reviewed by the European Commission (EC), which has the authority to approve medicines for the European Union (EU). The EC decision is expected within three months and will apply to all 28 countries of the European Union, Norway, Iceland and Liechtenstein.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.


Related News

View all news

IndiGo launches new offer for domestic, international flights: Report

InterGlobe Aviation (IndiGo) has reportedly launched new offer at Rs 899 for domestic flights and Rs 3,199 for international flights in its new sale. The 'Fare-tastic Winters!' offer is starting from November......

HDFC Bank to hike stake in CCIL

HDFC Bank will acquire 4% equity stake in Clearing Corporation of India (CCIL). The Bank currently holds 5% of the total equity capital of CCIL. Hence, it is proposed to increase the stake in CCIL from......

Indiabulls Housing Finance raises Rs 23,615 crore in last 2 months

Indiabulls Housing Finance has raised Rs 23,615 crore in the last 2 months from 32 financial institutions in various debt instruments, securitization and sanctions. Of the total of Rs 23,615 crore raised,......

Top News

View all news

Megastar Foods planning to incorporate subsidiary

Megastar Foods is planning to incorporate a subsidiary Company. The meeting of the Board of Directors of the company is scheduled to be held on November 27, 2018, to consider the same. Megastar Foods is......

Lupin launches generic Tetrabenazine Tablets

Lupin has launched Tetrabenazine Tablets, 12.5 mg and 25 mg having received an approval from the United States Food and Drug Administration (USFDA) earlier. Lupin's Tetrabenazine Tablets, 12.5 mg and 25......

UPL's arm signs definitive agreement to acquire entire stake of IBC

UPL's wholly owned subsidiary-- UPL Corporation, Mauritius has signed a definitive agreement to acquire directly or through its subsidiaries 100% of the shares of INDUSTRIAS BIOQUIM CENTROAMERICANA, SOCIEDAD......